Hikma Pharmaceuticals
| Use attributes for filter ! | |
| Stock price | HIK |
|---|---|
| Disclaimer | |
| Headquarters | London |
| United Kingdom | |
| Ceo | Sigurdur Olafsson |
| Revenue | 2. 076 billion USD (2018) |
| Founders | Samih Darwazah |
| Founded | Amman |
| Jordan | |
| Subsidiaries | Promopharm |
| West-Ward Pharmaceuticals | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2258030 |
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded in Amman, Jordan in 1978 by Samih Darwazah. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
